Targeted Therapies Do Not Increase Cardiovascular Risk in Psoriasis
Researchers sought to investigate the effect of targeted therapies on cardiovascular risk in psoriasis and psoriatic arthritis.
Researchers sought to investigate the effect of targeted therapies on cardiovascular risk in psoriasis and psoriatic arthritis.
In a cross-sectional study, researchers addressed whether medical cannabis is changing the use of other pain treatments among adults with noncancer chronic pain.
Researchers evaluated whether metformin use prior to hospitalization for community-acquired pneumonia decreases the risk of mortality in older patients with diabetes.
Researchers sought to characterize real-world efficacy of repeated ketamine infusions for treatment-resistant bipolar depression assessing symptoms of depression, anxiety, suicidality, and functioning.
These are the clinical trials that led to the FDA’s approval of aducanumab and lecanemab for early AD, plus, the concerns that loom.
Researchers sought to explore the relationship between the initiation of MS treatment and patient-reported symptoms and health-related quality of life.
A pragmatic, parallel-group, randomized control trial was conducted between 2020 and 2021 to ascertain whether a lifestyle modification program had an effect on patients with treatment-resistance depression.
Researchers evaluated the efficacy and safety of intermediate-dose vs low-dose low-molecular-weight heparin in pregnant women with a history of venous thromboembolism.
Can reducing RNT with psychological treatment approaches help improve youth depression and anxiety?
Researchers assessed the relationship between oral anticoagulation for patients with COVID-19 and AF and incidence of in-hospital thrombotic events and death.